Literature DB >> 7560864

Histological grading and staging of chronic hepatitis.

K Ishak1, A Baptista, L Bianchi, F Callea, J De Groote, F Gudat, H Denk, V Desmet, G Korb, R N MacSween.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7560864     DOI： 10.1016/0168-8278(95)80226-6

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  1190 in total

1.  The Effect Of Long Term and High Dose Interferon Treatment In Chronic Hepatitis C.

Authors:  Gábor Horváth; Gyula Stotz; Gyula Tolvaj; Henrik Osztrogonácz; Károly Dávid
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

2.  Expression of perforin and Fas ligand mRNA in the liver of viral hepatitis.

Authors:  M Tagashira; K Yamamoto; K Fujio; T Nagano; R Okamoto; N Ibuki; K Yabushita; S Matsumura; N Okano; T Tsuji
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

3.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

4.  HCV infection should be managed in specialist centres.

Authors:  J L Brown
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

5.  Digital quantification is more precise than traditional semiquantitation of hepatic steatosis: correlation with fibrosis in 220 treatment-naïve patients with chronic hepatitis C.

Authors:  Sekou R Rawlins; Ola El-Zammar; J Michael Zinkievich; Nancy Newman; Robert A Levine
Journal:  Dig Dis Sci       Date:  2010-05-12       Impact factor: 3.199

6.  Fluoxetine disposition in patients with chronic hepatitis C treated with interferon-α.

Authors:  Mario Furlanut; Giorgio Soardo; Debora Donnini; Leonardo Sechi; Loretta Franceschi
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

7.  Apoptosis-related proteins, BCL-2, BAX, FAS, FAS-L and PCNA in liver biopsies of patients with chronic hepatitis B virus infection.

Authors:  J Ehrmann; D Galuszková; J Ehrmann; I Krc; V Jezdinská; B Vojtések; P G Murray; Z Koláo
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

8.  Clinicopathological Features of Autoimmune Hepatitis with IgG4-Positive Plasma Cell Infiltration.

Authors:  Yoshitaka Arase; Koshi Matsumoto; Kazuya Anzai; Kota Tsuruya; Satoru Sugiyama; Shihou Yoshihara; Shunji Hirose; Haruki Uojima; Hisashi Hidaka; Takahide Nakazawa; Ryuzo Deguchi; Seiichiro Kojima; Shinji Takashimizu; Koichi Shiraishi; Takayuki Shirai; Tatehiro Kagawa
Journal:  Dig Dis       Date:  2020-07-30       Impact factor: 2.404

9.  Serum prolidase and IGF-1 as non-invasive markers of hepatic fibrosis during four different periods after bile-duct ligation in rats.

Authors:  Orhan Tarçin; Nursal Gedik; Berna Karakoyun; Veysel Tahan; Gagan Sood; Ciğdem Celikel; Nurdan Tözün
Journal:  Dig Dis Sci       Date:  2007-11-13       Impact factor: 3.199

10.  Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B.

Authors:  Bulent Baran; Ozlem Mutluay Soyer; Asli Cifcibasi Ormeci; Suut Gokturk; Sami Evirgen; Hamza Ugur Bozbey; Filiz Akyuz; Cetin Karaca; Kadir Demir; Fatih Besisik; Derya Onel; Mine Gulluoglu; Selim Badur; Sabahattin Kaymakoglu
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.